Static Chart BioXcel Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-20 EST			5-day change	1st Jan Change
1.890 ^USD	+2.72%		-7.80%	+18.12%

01-20	BioXcel Therapeutics, Inc. Announces the Submission of Supplemental New Drug Application to the U.S. Food and Drug Administration for IGALMI	CI
01-20	BioXcel Therapeutics, Inc. Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI Label Expansion in the At-Home Setting	CI

Duration

Period